Januvia

Attention: Recent medical research suggests that certain diabetes medications, including brand name drugs such as Januvia, Janumet, Byetta, Bydureon and Victoza, are potentially linked to an increased risk of pancreatic cancer or pancreatitis side effects when compared to other diabetes treatment therapies.

The results of these independent studies has spurred the FDA to conduct a new investigation of the issue in 2013.

April 18, 2013 – The Institute for Safe Medical Practices or the ISMP, which monitors FDA MedWatch reports, focused on 5 widely used drug treatments for type 2 diabetes, including Byetta, Victoza, Januvia, Onglza and Tradjenta.

The released medical study reviewed the FDA adverse drug events over 12 months.

Based on its’ findings, ISMP is calling for stronger alerts on the prescribing information, as well as new studies on the long-term effects of these diabetes treatment drugs and the association with thyroid and pancreatic cancer.

IF YOU HAVE BEEN DIAGNOSED WITH PANCREATIC CANCER AND TOOK THE DRUG JANUVIA OR RELEATED RX DRUGS – CALL US DAY OR NIGHT FOR MORE INFORMATION.

CALL 800-862-1260.

March 14, 2013 - The FDA has requested additional information from a group of academic researchers whose findings suggest an increased risk of pancreatitis and pre-cancerous cellular changes in patients with type 2 diabetes treated with a class of drugs called incretin mimetics, including exenatide (Byetta, Bydureon), liraglutide (Victoza), sitagliptin (Januvia, Janumet, Janumet XR, Juvisync), saxagliptin (Onglyza, Kombiglyze XR), alogliptin (Nesina, Kazano, Oseni), and linagliptin (Tradjenta, Jentadueto).

Doctors, as well as patients with type 2 diabetes who have been treated with this class of drugs, are encouraged to report adverse events to the FDA MedWatch program.

IF YOU HAVE BEEN DIAGNOSED WITH PANCREATIC CANCER AND TOOK THE DRUG JANUVIA OR RELEATED RX DRUGS – CALL US DAY OR NIGHT FOR MORE INFORMATION.

CALL 800-862-1260.

March 26, 2013 – UCLA and University of Florida researchers examine pancreatic tissue of recent organ donors. Investigators reported that the pancreatic mass of those taking GLP-1[diabetes patients] was increased 40% compared to that of the other diabetes drugs or non-diabetic controls.

The study also identified precancerous growths in the pancreas of those who had been treated with GLP-1 agents and a six-fold increase in beta cells compared with the diabetes comparators.

February 25, 2013 – A case study of Blue Cross/Blue Shield health plan insurance claims shows a 2.2-fold increased risk of hospitalization for acute pancreatitis among patients treated with sitagliptin (Januvia, Janumet, Juvisync) and exenatide (Byetta, Bydureon). Pancreatitis is generally considered a risk factor for pancreatic cancer.

Generic and brand names for diabetes medications:

• Alogliptin
• Kazano
• Nesina
• Oseni
• Exenatide
• Byetta
• Bydureon
• Linagliptin
• Jentadueto
• Tradjenta
• Liraglutide
• Victoza
• Saxagliptin
• Kombiglyze XR
• Onglyza
• Sitagliptin
• Januvia
• Janumet
• Janumet XR
• Juvisync

Januvia was approved by the FDA in October 2006 for the treatment of diabetes. A study in 2011 found that using Januvia (sitagliptin) to treat type 2 diabetes may increase the risk of pancreatic cancer by 2.7 times. The study was published in the journal Gastroenterology and compared the incidence rates of pancreas cancer reported by patients using one of several different diabetes medications. The researchers found there was a 2.7-fold likelihood the disease would be reported by sitagliptin users. If you or a loved one used Januvia, and were later diagnosed with pancreatic cancer, you may be eligible to receive compensation.

We believe that the manufacturer of Januvia should be accountable for any harm they are legally responsible for.

IF YOU OR A LOVED ONE HAS BEEN DIAGNOSED WITH PANCREATIC CANCER AND TOOK THE DRUG JANUVIA OR RELEATED RX DRUGS – CALL US DAY OR NIGHT FOR MORE INFORMATION.

CALL 800-862-1260.

There is no cost to talk to us about your case. We are here to listen, offer our advice and help you determine what your legal options are. If you decide to pursue a claim, there are never any fees unless we recover compensation for you.